Tools and resources

About this document

About this document

This document summarises the process used for developing NICE clinical guidelines from November 2012 onwards, including:

  • how Guideline Development Group members are selected

  • how organisations can register as stakeholders

  • the stages when registered stakeholders can contribute to the development of a clinical guideline.

This edition replaces the January 2009 edition of 'The guideline development process: an overview for stakeholders, the public and the NHS' (reference number N1739).

Other documents on the clinical guidelines process are available from the NICE website:

We welcome comments on this document. These should be emailed to:

Nothing in this document shall restrict any disclosure of information by NICE that is required by law (including in particular but without limitation the Freedom of Information Act 2000).

National Institute for Health and Clinical Excellence

Level 1A, City Tower
Piccadilly Plaza
Manchester, M1 4BT

Published by the National Institute for Health and Clinical Excellence

November 2012

© National Institute for Health and Clinical Excellence, 2012. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

This page was last updated: